ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

CCIRC Holds Groups To 1980 Spending Levels, But They May Get Even Less

January 9, 1981

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

Letter to the Editor

February 21, 2003

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983